BX Swiss TOP 30 CHF

BX Swiss TOP 30 CHF handeln
1.371,11 PKT -4,74 PKT -0,34 %
finanzen.net zero
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Smartphone

WKN SL0CLV

ISIN DE000SL0CLV3


Analysen zu BX Swiss TOP 30 CHF-Werten

Datum Rating Analyst
12.08.15 Nestlé Sell Goldman Sachs Group Inc.
11.08.15 UBS Neutral Credit Suisse Group
11.08.15 Zurich Insurance overweight Barclays Capital
11.08.15 Swiss Re overweight Morgan Stanley
10.08.15 Zurich Insurance Verkaufen DZ-Bank AG
10.08.15 Zurich Insurance buy Joh. Berenberg, Gossler & Co. KG (Berenberg Bank)
07.08.15 UBS buy Joh. Berenberg, Gossler & Co. KG (Berenberg Bank)
07.08.15 Novartis buy Jefferies & Company Inc.
07.08.15 Holcim Neutral UBS AG
07.08.15 Roche buy Jefferies & Company Inc.
06.08.15 Zurich Insurance Sell S&P Capital IQ
06.08.15 Holcim overweight JP Morgan Chase & Co.
05.08.15 Swiss Re buy Goldman Sachs Group Inc.
05.08.15 UBS buy Citigroup Corp.
04.08.15 Swiss Re Underperform BNP PARIBAS
04.08.15 Holcim Neutral Goldman Sachs Group Inc.
03.08.15 Holcim Neutral BNP PARIBAS
03.08.15 Holcim buy Kepler Cheuvreux
31.07.15 Holcim Neutral BNP PARIBAS
31.07.15 Swiss Re neutral Barclays Capital
30.07.15 Swiss Re buy S&P Capital IQ
30.07.15 Holcim buy Deutsche Bank AG
29.07.15 Holcim kaufen S&P Capital IQ
29.07.15 UBS Underperform BNP PARIBAS
29.07.15 Zurich Insurance Neutral UBS AG
29.07.15 Roche buy UBS AG
29.07.15 Roche overweight JP Morgan Chase & Co.
28.07.15 Holcim Reduce HSBC
28.07.15 UBS overweight JP Morgan Chase & Co.
28.07.15 Holcim Neutral UBS AG
28.07.15 Roche overweight Barclays Capital
27.07.15 UBS Strong Buy S&P Capital IQ
27.07.15 Roche Conviction Buy List Goldman Sachs Group Inc.
27.07.15 Novartis Neutral Goldman Sachs Group Inc.
27.07.15 ABB (Asea Brown Boveri) Neutral Nomura
27.07.15 UBS kaufen Independent Research GmbH
27.07.15 Novartis buy UBS AG
27.07.15 UBS Sell Société Générale Group S.A. (SG)
24.07.15 Roche overweight Morgan Stanley
24.07.15 UBS kaufen Morgan Stanley